News

EyeGate Pharma’s broad iontophoresis patent portfolio for corneal collagen cross-linking will be held as exclusive license by Avedro Inc. Delivery approach provides potential additional benefits to current formulation.

Prevent Blindness America offers free educational materials to help the public, educators, and health professionals address diabetes and its visual consequences.

In a pilot phase II study, an intracanalicular plug (OTX-TP2, Ocular Therapeutics) shows promise for lowering IOP and increasing compliance with the treatment regimen.

Mitomycin C following wavefront-guided PRK for high myopia had no dose-dependent effect on haze scores throughout the study.

Nicox S.A. announced the U.S. launch of a point-of-care diagnostic test (AdenoPlus) that aids in the differential diagnosis of acute conjunctivitis.

SARcode Bioscience Inc. announced the topline results from OPUS-1, a pivotal phase III study of lifitegrast ophthalmic solution 5.0% for the treatment of dry eye disease.

Current multifocal IOLs have some limitations that in specific situations are overcome with the dual-optic accommodating IOL (Synchrony, Abbott Medical Optics).

The Glaucoma Foundation has announced George L. Spaeth, MD, as the 2012 recipient of the foundation’s Dr. Robert Ritch Award for Innovation and Excellence in Glaucoma.

A new strategy that uses the femtosecond laser to make a side cut for postLASIK re-treatment may reduce the incidence of epithelial ingrowth.

The FDA advises health-care professionals to follow up with patients for whom they administered an injectable product purchased from or produced by NECC.

The FDA has approved ocriplasmin (Jetrea, ThromboGenics) for the treatment of symptomatic vitreomacular adhesion (VMA).

A Canadian trial including 120 subjects is investigating the safety and efficacy of an acrylic, foldable, single-piece, angle-supported phakic IOL (AcrySof Cachet, Alcon).

FCI Ophthalmics has received 510(k) clearance for a pushed monocanalicular nasolacrimal intubation stent (Masterka).

The FDA has approved cysteamine ophthalmic solution (Cystaran, Sigma-Tau Pharmaceuticals) 0.44% for corneal cystine crystal accumulation in patients with cystinosis.

The FDA has cleared the additional indication of corneal flap creation in refractive surgical procedures for a femtosecond laser platform (LenSx Laser, Alcon).

A video description of Cataract Surgery: Telling It Like It Is!, cataract meeting organized by Robert H. Osher, MD.

To clarify whether total intracranial CSF volume increases in IIH, researchers prospectively studied MRI-derived measures of total cranial, ventricular, and extraventricular CSF volumes in patients with IIH and controls. Results showed that the extraventricular CSF space was significantly greater in the patient group versus the controls. The ventricular volume was the same between the two groups.

Aflibercept (Eylea, Regeneron) has gained FDA approval for treatment of macular edema following CRVO and recommendation for approval by the CHMP for treatment of neovascular AMD.

A phase IIa proof of concept study of a novel rho-kinase (ROCK) inhibitor (AMA0076, Amakem NV) is now underway in patients with glaucoma and ocular hypertension.

QLT Inc. announces that it has completed sale of verteporfin for injection (Visudyne) to Valeant Pharmaceuticals International Inc.

Certain eye movement patterns seem to be associated with better face recognition performance in patients with central glaucomatous visual field loss.

A scientific research grant to cover studies related to dry eye and ocular surface disease will be awarded by CLAO ERF in association with the SSF.

AcuFocus Inc. has received approval from Health Canada to market and sell the Kamra inlay, an innovative corneal inlay to treat presbyopia, within Canada.

The FDA has granted additional labeling indications for besifloxacin ophthalmic suspension 0.6% (Besivance, Bausch + Lomb).

A study provides new insight on the risk of early ocular surface-related complications among patients undergoing CXL for keratoconus.

The iDesign aberrometer (Abbott) provides an advanced, high-definition measurement device for wavefront-guided LASIK procedures.

The AcrySof IQ ReSTOR +2.5-D IOL offers sharp distance vision with an additional range of vision beyond a standard monofocal lens.

In today's blog from ESCRS, Mark Dlugoss, Ophthalmology Times editor-in-chief, discusses ophthalmic technologies and FDA-related availability issues.